Your Followed Topics

Top 8 world health organization News Today

#1
WHO provides emergency funds to scale up health response in cyclone-hit Sri Lanka
#1 out of 867.19%
world1h ago

WHO provides emergency funds to scale up health response in cyclone-hit Sri Lanka

https://www.who.int/southeastasia/news/detail/02-12-2025-who-provides-emergency-funds-to-scale-up--health-response-in-cyclone-hit-sri-lanka
Who.int
  • The World Health Organization provided US$175,000 in emergency funds to reinforce Sri Lanka's health response after the cyclone, including rapid medical teams.
  • Funds will back rapid response teams to deliver trauma care, support pregnant women and children, and strengthen surveillance systems.
  • Cyclone Ditwah caused extensive flooding, landslides, and damage, prompting international health support.
  • WHO is leading the health sector response in collaboration with national authorities and partners.
  • SEARHEF funds are part of a regional mechanism to support life-saving health interventions after emergencies.
  • Sri Lanka declared a state of emergency and requested international assistance for multi-sector recovery needs.
  • WHO aims to ensure continuity of essential services and monitor disease threats across 25 districts.
  • WHO is coordinating with national authorities and partners for timely, life-saving health interventions.
  • The relief aims to support essential health services and timely outbreak detection across affected communities.
Vote 0
0
#2
World AIDS Day
#2 out of 8562.0 est. views
health1d ago

World AIDS Day

https://www.who.int/southeastasia/news/detail/01-12-2025-world-aids-day
Who.int
  • WHO Southeast Asia marks World AIDS Day 2025, urging action to overcome disruptions and transform the AIDS response.
  • Region reports 3.5 million people living with HIV and 88,000 new infections last year, with 50,000 HIV-related deaths.
  • Maldives becomes the first country worldwide to validate Triple Elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B.
  • WHO outlines six strategic actions to strengthen AIDS responses in the region.
  • Action includes accelerating the 95-95-95 cascade with same-day ART and expanded self-testing.
  • Integration of EMTCT with reproductive-health services is a priority.
  • WHO calls for equitable access to new prevention tools and medicines.
  • Investment in data systems and AI-enabled solutions is urged to improve surveillance.
  • Financing and system resilience are emphasized to maintain essential services during crises.
  • WHO emphasizes empowering communities and upholding rights in the AIDS response.
  • WHO remains committed to supporting national responses and closing remaining gaps.
Vote 0
0
#3
New prevention tools and investment in services essential in the fight against AIDS
#3 out of 8
health1d ago

New prevention tools and investment in services essential in the fight against AIDS

https://www.who.int/news/item/01-12-2025-new-prevention-tools-and-investment-in-services-essential-in-the-fight-against-aids
Who.int
  • WHO calls for rapid, global access to new HIV prevention tools, including lenacapavir.
  • LEN is a long-acting injectable HIV prevention option gaining regulatory approvals in several countries.
  • Funding cuts disrupted HIV prevention, treatment, and testing services in 2025.
  • World AIDS Day theme emphasizes solidarity and investment to protect communities at risk.
  • WHO stresses integration of HIV services into primary health care for better access.
  • Global AIDS response shows momentum despite funding challenges and donor gaps.
  • WHO notes that PrEP access declined as donor funding fell.
  • WHO aims to end AIDS by 2030 with sustained investment and rights-based care.
  • Global partners include CIFF, Gates Foundation, and Unitaid to improve LEN access.
Vote 0
0
#4
WHO issues guidance on GLP-1 drugs for obesity, calls them a "scientific breakthrough" and "new chapter"
#4 out of 869.1K est. views
health1d ago

WHO issues guidance on GLP-1 drugs for obesity, calls them a "scientific breakthrough" and "new chapter"

https://www.cbsnews.com/news/who-guidance-glp-1-drugs-obesity/https://www.euronews.com/health/2025/12/01/weight-loss-drugs-and-healthy-lifestyles-recommended-to-treat-obesity-who-sayshttps://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
Cbsnews.com and 6 more
  • The World Health Organization now recommends GLP-1 drugs for adults with obesity as part long-term treatment, alongside behavioral therapy and monitoring.
  • The guidance marks a shift from viewing obesity as a lifestyle issue to a chronic disease needing ongoing, comprehensive care.
  • Global access and affordability are prioritized, with urgent actions urged on manufacturing, pricing, and health system readiness.
Vote 18
0
#5
Ozempic-style drugs should be available to all, not just the rich, says WHO
#5 out of 8
health23h ago

Ozempic-style drugs should be available to all, not just the rich, says WHO

https://www.politico.eu/article/ozempic-style-drugs-available-to-all-not-just-the-rich-says-world-health-organizationo/
Politico.eu
  • The World Health Organization recommends broader access to GLP-1 weight‑loss drugs beyond wealthier nations.
  • WHO proposes tiered pricing and voluntary licensing to boost generic GLP‑1 production.
  • The guidance is conditional due to limited long‑term data on GLP‑1 safety and efficacy.
  • Countries with the highest obesity rates include regions in the Middle East, Latin America and Pacific islands.
  • Wegovy and other GLP‑1s are currently available in only a fraction of markets.
  • Generics could enter once key patents expire, aiding price reductions.
  • Indian generics firm Dr. Reddy’s plans a global semaglutide‑based product launch in 2026.
  • WHO emphasizes need for health systems to manage rollout and cold chain storage.
  • The guidance advocates wider access as part of a comprehensive obesity strategy beyond medication alone.
  • The article notes that current access is limited and prices may fall with generics, but rollout remains complex.
Vote 0
0
#6
WHO warning over shortage of obesity jabs
#6 out of 839.9K est. views
health23h ago

WHO warning over shortage of obesity jabs

https://www.bbc.co.uk/news/articles/cze8n0753zzohttps://www.bbc.com/news/articles/cze8n0753zzo
Bbc.co.uk and 1 more
  • The WHO warns that fewer than 10% of eligible people can access obesity jabs, signaling a global access gap even as obesity rises toward 2030 projections.
  • GLP-1 therapies have been added to the WHO's essential medicines list to push wider country-level access.
  • Obesity is framed by WHO as a chronic disease requiring comprehensive, lifelong care rather than a one-off treatment.
  • High costs, limited production capacity, and supply-chain constraints are major barriers to universal access to obesity injections.
  • Patent expirations for semaglutide in 2026 could enable cheaper copies in several countries, potentially expanding supply.
  • WHO urges voluntary licensing to help expand access to affordable GLP-1 versions of the drug.
  • GLP-1 therapies work by slowing digestion and increasing fullness, aiding weight loss when paired with lifestyle changes.
  • Weight regain remains a risk after stopping GLP-1 therapy, with cravings often returning within about a year.
  • Access to obesity jabs should be paired with healthier environments to support lasting weight management.
Vote 1
0
#7
Weight loss jabs conditionally backed to tackle obesity by World Health Organization
#7 out of 8
health23h ago

Weight loss jabs conditionally backed to tackle obesity by World Health Organization

https://news.sky.com/story/weight-loss-jabs-conditionally-backed-to-tackle-obesity-by-world-health-organization-13477934
News.sky.com
  • The World Health Organization conditionally recommends GLP-1 weight loss therapies for adults with obesity as part of long-term obesity care.
  • The WHO notes obesity affects more than one billion people worldwide and could rise to two billion by 2030.
  • Access to GLP-1 therapies remains a major barrier, with projections that fewer than 10% who could benefit will receive them by 2030.
  • The guidance recommends combining weight loss drugs with a healthy diet and physical activity for adults.
  • The WHO plans to issue guidance for treating obesity in children and adolescents next week.
  • The WHO notes ongoing access challenges even as GLP-1 therapies become more available worldwide.
  • Ozempic, Wegovy, Mounjaro, and Zepbound are among the GLP-1 medications referenced in the guidance.
  • NHS England has faced delays in offering obesity treatments to patients, with only a minority of NHS boards providing the drugs as of August.
  • Top health guidance emphasizes monitoring and long-term support after completing obesity treatment.
  • The guidance will shape obesity treatment policy as WHO positions GLP-1 therapies within a comprehensive care framework.
Vote 0
0
#8
Kids under 5 most vulnerable as 'world's most contagious virus' cases spike
#8 out of 8
health14h ago

Kids under 5 most vulnerable as 'world's most contagious virus' cases spike

https://www.dailystar.co.uk/news/kids-under-5-most-vulnerable-36336559
Dailystar.co.uk
  • Measles outbreaks tripled compared with pre-COVID levels, according to WHO.
  • About 11 million measles cases were recorded last year, up from 10.4 million in 2023.
  • England's MMR uptake sits at 88.9%, its lowest in 15 years, with gaps in vaccination coverage.
  • The MMR vaccine remains the best protection against contracting measles and spreading it.
  • WHO Director-General Tedros warned measles does not respect borders and requires global action.
  • Major outbreaks have occurred across regions including the West Midlands, North West and London.
  • Among the under-protected, 75% live in the African and Eastern Mediterranean regions.
  • Measles can cause serious complications like blindness, brain swelling and pneumonia.
  • Experts urge continued vaccination to close immunity gaps and prevent outbreaks.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement